| Literature DB >> 32194016 |
Sharifah Sekalala1, Haleema Masud2, Rebekah Thomas Bosco3.
Abstract
Background: The presence of corruption in State institutions and broader society presents a significant obstacle to the right to the enjoyment of the highest attainable standard of health. The Universal Periodic Review, a Member State-led peer review system administered by the Human Rights Council, is a core tool of human rights, including the right to health accountability. This paper builds on existing research to examine processes that support State engagement on the issue of corruption. We identify opportunities for States to use the Universal Periodic Review to support anti-corruption, transparency and accountability to control corruption in the health-care sector.Entities:
Keywords: Corruption; accountability; health sector; human rights; human rights mechanisms
Mesh:
Year: 2020 PMID: 32194016 PMCID: PMC7170379 DOI: 10.1080/16549716.2019.1699343
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Types of corruption in the health sector [3].
| Area of process | Types of corruption and problems | Results |
|---|---|---|
| Construction and rehabilitation of health facilities | Bribes, kickbacks and political considerations influencing the contracting process Contractors fail to perform and are not held accountable | High-cost, low-quality facilities and construction work. Construction investments influences by bribes may also lead to further waste if recurrent costs to operate facilities are inadequately financed Location of facilities that does not correspond to need, resulting in inequities in access Biased distribution of infrastructure favoring urban- and elite-focused services, high technology |
| Purchase of equipment and supplies including drugs | Bribes, kickbacks and political considerations influence specifications and winners of bids Collusion or bid rigging during procurement Lack of incentives to choose low-cost and high-quality suppliers Unethical drug promotion Suppliers fail to deliver and are not held accountable | High-cost, inappropriate, or duplicative drugs and equipment Irrational prescribing Substandard equipment and drugs Inequities due to inadequate funds left to provide for all needs |
| Distribution and use of drugs and supplies in service delivery | Theft (for personal use) or diversion (for private sector resale) of drugs and supplies at storage and distribution points Sale of drugs or supplies that were supposed to be free | Lower utilization Patients do not get proper treatment Patients must make informal payments to obtain drugs Interruption of treatment or incomplete treatment, leading to the development of antimicrobial resistance |
| Regulation of quality in products, services, facilities and professionals | Bribes to speed process or gain approval for drug registration, drug quality inspection, or certification of good manufacturing practices Bribes or political considerations influence results of inspections or suppress findings Biased application of sanitary regulations for restaurants, food production and cosmetics Biased application of accreditation, certification, or licensing procedures and standards | Subtherapeutic or fake drugs allowed on the market Marginal suppliers are allowed to continue participating in bids, getting government work Increased incidence of food poisoning Spread of infectious and communicable diseases Poor-quality facilities continue to function Incompetent or fake professionals continue to practice |
| Human resources management | Bribes to gain place in medical school or other training Bribed to obtain passing grades Political influence, nepotism in selection of candidates for training opportunities or positions Bribes or regular payoffs to obtain/maintain position in government health services or medical facilities | Incompetent professionals practicing medicine or working in health professions Loss of faith and freedom due to unfair system Poor resource allocation decisions due to inaccurate health expenditure data (doesn’t reflect payoffs to superiors, effectively a tax on salaries) Increased informal payments as health workers seek to finance required pay-offs to keep their job Violation of individual rights Patients who receive unnecessary or harmful treatment |
| Medical research | Pseudo trials funded by drug companies that are really designed for marketing purposes Misunderstanding of informed consent and other issues of adequate standards in developing countries | Violation of individual rights Biases and inequities in research Patients who receive unnecessary or harmful treatment |
| Financial management | Embezzlement of budget allocation Theft of user fee revenue False recording of revenue to inflate or obscure financial position from stockholder or analysts (affects private health firms) Billing or reimbursement fraud | Reduced availability of public health programs and government medical services Lower quality of care Bankruptcy and loss of entrusted resources Loss of state dollars to fraud |
| Service delivery | Doctors use public facilities and equipment to see private patients Diversion of patients to private practice or privately owned ancillary services Utilization that is not medically indicated, in order to maximize income Withholding of care that is medically indicated (to solicit bribes) Absenteeism and shirking Informal payments required from patients for services that were supposed to be free of charge | Government loses value of investments without adequate compensation Employees are not available to serve patients, leading to a lower volume of services and unmet needs, and higher unit costs for health services actually delivered Reduced utilization of services by patients who cannot pay Impoverishment as citizens borrow or sell assets to pay for health care Loss of citizen faith in government |
From Fighting Corruption in Developing Countries: Strategies and Analysis, edited by Bertram I. Spector. Copyright © 2005 by Lynne Rienner Publishers, Inc. Used with permission of the publisher.
| No. | Type of recommendations | Explanation |
|---|---|---|
| 1 | International human rights mechanisms | Covers recommendations that encourage states to ratify international human rights treaties; invite UN Special Rapporteurs; implement recommendations from treaty bodies’ concluding observations; implement comments or other relevant documents. |
| 2 | Legislation | Covers recommendations that approve or call for changes in legislation; changes to the legal framework; the repeal of certain legal provisions. |
| 3 | National funding | Covers recommendations to allocate or increase funds to a certain issue that engages the right to health; the health sector or health services. |
| 4 | International cooperation (funding and technical assistance) | Covers recommendations that engage the international community, assistance, cooperation and funding, either by encouraging the State under review to seek assistance from other states, or by requesting the State under review to share its expertise in a particular region. |
| 5 | Policies and programmes | Covers recommendations concerned with the enforcement or implementation of human rights through policies, procedures, programmes, services or other facilities. |
| 6 | Other | Covers recommendations that refer to issues of health but do not fit any of the above categories. |
From WHO and Human Rights Centre Clinic, University of Essex (permissions pending).
Figure 1.Distribution of corruption and health-related topics in the recommendations from the 29th session of the third cycle of UPR (January 2018).
Figure 2.Types of health-related recommendations in the 29th session of the third cycle of the UPR (January 2018) [recommendations could be classified in more than one type].
Figure 3.Distribution of specific health-related issues in the recommendations in the 29th session of the third cycle of the UPR.
LGBTI: Health of Lesbian, Gay, Bisexual, Transgender or Intersex persons; STIs: Sexually Transmitted Infections; TB: Tuberculosis.
Discussion of corruption in the UPR reports.
| Country | National report | Compilation of UN information | Summary of stakeholders submissions | Questions submitted in advance | Outcome report | ||
|---|---|---|---|---|---|---|---|
| Summary of national report | Interactive dialogue | Recommendations | |||||
| Bahamas | X | - | - | - | X | - | - |
| Barbados | X | - | - | - | X | - | X |
| Botswana | X | - | - | - | - | - | - |
| Burundi | X | - | X | - | - | X | X |
| France | - | - | - | - | - | - | - |
| Israel | - | - | - | - | - | - | - |
| Liechtenstein | X | X | X | - | - | - | X |
| Luxembourg | - | - | - | X | - | X | - |
| Mali | X | - | X | - | - | - | - |
| Montenegro | X | X | X | X | X | X | X |
| Romania | X | X | - | X | - | X | X |
| Serbia | X | - | X | - | X | X | X |
| Tonga | X | - | X | - | - | - | - |
| UAE | X | - | - | - | - | - | - |
| Total | 11 | 3 | 6 | 3 | 4 | 5 | 6 |
X indicates a mention of corruption for one or more times in the relevant reports (sections).
Number of corruption and health-related topics in the recommendations of the 29th session of the third cycle of UPR.
| Recommendations | |||||
|---|---|---|---|---|---|
| Country | Total | Health-related | Corruption in health sector | Corruption (General) | |
| 1 | Bahamas | 141 | 98 | 0 | 0 |
| 2 | Barbados | 137 | 105 | 0 | 1 |
| 3 | Botswana | 207 | 129 | 0 | 0 |
| 4 | Burundi | 237 | 99 | 0 | 1 |
| 5 | France | 297 | 112 | 0 | 0 |
| 6 | Israel | 240 | 51 | 0 | 0 |
| 7 | Liechtenstein | 126 | 40 | 0 | 1 |
| 8 | Luxembourg | 149 | 52 | 0 | 0 |
| 9 | Mali | 194 | 83 | 0 | 0 |
| 10 | Montenegro | 169 | 75 | 0 | 6 |
| 11 | Romania | 203 | 113 | 2 | 4 |
| 12 | Serbia | 190 | 67 | 0 | 2 |
| 13 | Tonga | 110 | 62 | 0 | 0 |
| 14 | UAE | 232 | 82 | 0 | 0 |
| Total | 2632 | 1168 | 2 | 15 | |